The Discounted Cash Flow (DCF) valuation of Innovative Pharmaceutical Biotech Ltd (399.HK) is (11.99) HKD. With the latest stock price at 0.37 HKD, the upside of Innovative Pharmaceutical Biotech Ltd based on DCF is -3340.9%.
Based on the latest price of 0.37 HKD and our DCF valuation, Innovative Pharmaceutical Biotech Ltd (399.HK) is a sell. selling 399.HK stocks now will result in a potential gain of 3340.9%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 3.7% - 4.7% | 4.2% |
| Long-term Growth Rate | 3.0% - 3.4% | 3.2% |
| Fair Price | (43.08) - (7.30) | (11.99) |
| Upside | -11744.1% - -2073.7% | -3340.9% |